NCT06639984View on ClinicalTrials.gov

Psyllium in Pediatric IBS

PHASE2RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Psyllium (0.7 g/year of age per day)

Psyllium (0.7 g/year of age per day) (Konsyl Pharmaceuticals, Easton, MD)

DRUG

Psyllium (0.5 g/year of age per day)

Psyllium (0.5 g/year of age per day) (Konsyl Pharmaceuticals, Easton, MD)

DRUG

Placebo

Placebo (0.7 g/year of age glucose) (Staleydex 333; Tate \& Lyle, Staley, London, UK)

OTHER

fructans

Daily dose 0.5 g/kg up to 19 grams, Orafti Synergy1

Trial Locations (1)

27705

RECRUITING

Duke University, Durham

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Dr Bruno Chumpitazi, M.D.

OTHER